BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 73925)

  • 1. Immunotherapy for acute myelogenous leukaemia.
    Harris R; Zuhrie SR
    Lancet; 1977 Dec; 2(8050):1228. PubMed ID: 73925
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for acute myelogenous leukaemia.
    Powles R
    Br J Cancer Suppl; 1973 Aug; 1():262-5. PubMed ID: 4531352
    [No Abstract]   [Full Text] [Related]  

  • 3. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
    Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
    Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunotherapy trials on acute lymphoid leukemia lymphosarcoma and acute myeloid leukemia.
    Mathe G; Schwarzenberg L; Delgado M; De Vassal F
    Eur J Cancer (1965); 1977; 13(4-5):445-55. PubMed ID: 326558
    [No Abstract]   [Full Text] [Related]  

  • 5. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 7. HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.
    Klouda TP; Lawler SD; Powles RL; Oliver RT; Grant CK
    Transplantation; 1975 Mar; 19(3):245-9. PubMed ID: 1094639
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
    Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
    Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of acute myeloid leukaemia. Medical Research Council.
    Br J Cancer; 1978 Jan; 37(1):1-14. PubMed ID: 339940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Jackson, Aspden Acute Myeloid Leukaemia model.
    Jackson RR; Birkhead BG; Bell R; Lister TA; Gregory WM
    J Oper Res Soc; 1982 Mar; 33(3):211-6. PubMed ID: 10298533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for acute myelogenous leukaemia.
    Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
    Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
    Powles RL; Russell J; Lister TA; Oliver T; Whitehouse JM; Malpas J; Chapuis B; Crowther D; Alexander P
    Br J Cancer; 1977 Mar; 35(3):265-72. PubMed ID: 322689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Bone-marrow culture in acute myeloid leukaemia.
    Goldman JM; Buskard NA; Th'ng KH
    Lancet; 1976 Jul; 2(7979):260. PubMed ID: 59277
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Immunotherapy for acute myeloid leukaemia.
    Lancet; 1974 May; 1(7862):846-7. PubMed ID: 4132795
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy of leukemia and lymphoma.
    Murphy S; Hersh E
    Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for acute myelogenous leukaemia.
    Powles R
    Ir J Med Sci; 1974 Jul; 0(0):suppl:10-3. PubMed ID: 4527840
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles and aims of the treatment of leukaemia (author's transl)].
    Krepler P
    Wien Klin Wochenschr; 1978 Dec; 90(23):817-25. PubMed ID: 369148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.